Literature DB >> 25271840

Diagnosing Lysosomal Storage Disorders: The GM2 Gangliosidoses.

Patricia Hall1, Sara Minnich, Claire Teigen, Kimiyo Raymond.   

Abstract

The GM2 gangliosidoses are a group of autosomal recessive lysosomal storage disorders caused by defective β-hexosaminidase. There are three clinical conditions in this group: Tay-Sachs disease (TSD), Sandhoff disease (SD), and hexosaminidase activator deficiency. The three conditions are clinically indistinguishable. TSD and SD have been identified with infantile, juvenile, and adult onset forms. The activator deficiency is only known to present with infantile onset. Diagnosis of TSD and SD is based on decreased hexosaminidase activity and a change in the percentage of activity between isoforms. There are no biochemical tests currently available for activator deficiency. This unit provides a detailed procedure for identifying TSD and SD in affected individuals and carriers from leukocyte samples, the most robust sample type available.
Copyright © 2014 John Wiley & Sons, Inc.

Entities:  

Keywords:  GM2 gangliosidosis; Sandhoff disease; Tay-Sachs disease; hexosaminidase

Mesh:

Year:  2014        PMID: 25271840     DOI: 10.1002/0471142905.hg1716s83

Source DB:  PubMed          Journal:  Curr Protoc Hum Genet        ISSN: 1934-8258


  6 in total

1.  GM2 Activator Deficiency Caused by a Homozygous Exon 2 Deletion in GM2A.

Authors:  Patricia L Hall; Regina Laine; John J Alexander; Arunkanth Ankala; Lisa A Teot; Hart G W Lidov; Irina Anselm
Journal:  JIMD Rep       Date:  2017-05-25

2.  Essential laboratory tests for medical education.

Authors:  Andrea T Deyrup; Danielle D'Ambrosio; Jeannie Muir; Barbara Knollmann-Ritschel
Journal:  Acad Pathol       Date:  2022-09-13

Review 3.  Therapeutic Strategies For Tay-Sachs Disease.

Authors:  Jaqueline A Picache; Wei Zheng; Catherine Z Chen
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

4.  An Infantile Case of Sandhoff Disease Presenting With Swallowing Difficulty.

Authors:  Jae-Gun Moon; Min-A Shin; Hannah Pyo; Seong-Uk Choi; Hyun-Kyung Kim
Journal:  Ann Rehabil Med       Date:  2017-10-31

Review 5.  Advances in Sphingolipidoses: CRISPR-Cas9 Editing as an Option for Modelling and Therapy.

Authors:  Renato Santos; Olga Amaral
Journal:  Int J Mol Sci       Date:  2019-11-24       Impact factor: 5.923

Review 6.  GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies.

Authors:  Andrés Felipe Leal; Eliana Benincore-Flórez; Daniela Solano-Galarza; Rafael Guillermo Garzón Jaramillo; Olga Yaneth Echeverri-Peña; Diego A Suarez; Carlos Javier Alméciga-Díaz; Angela Johana Espejo-Mojica
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.